Correlation Between Enanta Pharmaceuticals and Lipocine
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Lipocine, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Lipocine.
Diversification Opportunities for Enanta Pharmaceuticals and Lipocine
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Enanta and Lipocine is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Lipocine go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Lipocine
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Lipocine. In addition to that, Enanta Pharmaceuticals is 1.23 times more volatile than Lipocine. It trades about -0.33 of its total potential returns per unit of risk. Lipocine is currently generating about 0.06 per unit of volatility. If you would invest 510.00 in Lipocine on September 13, 2024 and sell it today you would earn a total of 21.00 from holding Lipocine or generate 4.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Lipocine
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Lipocine |
Enanta Pharmaceuticals and Lipocine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Lipocine
The main advantage of trading using opposite Enanta Pharmaceuticals and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Lipocine vs. Emergent Biosolutions | Lipocine vs. Bausch Health Companies | Lipocine vs. Neurocrine Biosciences | Lipocine vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |